We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.39%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$703M
AUM Growth
+$55.1M
(+8.5%)
Cap. Flow
-$4.95M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
521
New
17
Increased
5
Reduced
14
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$1.67M |
| 2 |
NSLR
Neostellar Capital Corp
NSLR
|
+$556K |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$554K |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$445K |
| 5 |
Theravance Biopharma
TBPH
|
+$380K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GameStop
GME
|
+$5.2M |
| 2 |
Intel
INTC
|
+$1.25M |
| 3 |
Apple
AAPL
|
+$1.03M |
| 4 |
Lam Research
LRCX
|
+$763K |
| 5 |
Procter & Gamble
PG
|
+$587K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Financials | 13.62% |
| 3 | Industrials | 13% |
| 4 | Healthcare | 12.82% |
| 5 | Consumer Discretionary | 9.22% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q1 2021 Portfolio in Review
As of Q1 2021, NJ State Employees Deferred Compensation Plan held 521 positions worth $703M, up 8.5% from $648M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.6%. NJ State Employees Deferred Compensation Plan opened 17 new positions and exited 7, leaving the 521-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- NJ State Employees Deferred Compensation Plan's largest Q1 2021 buy was Arena Pharmaceuticals Inc: 7,200 shares worth $500K.
- NJ State Employees Deferred Compensation Plan added most to Ionis Pharmaceuticals in Q1 2021, an estimated $1.67M increase.
- NJ State Employees Deferred Compensation Plan's biggest Q1 2021 reduction was GameStop, cutting an estimated $5.2M.
- NJ State Employees Deferred Compensation Plan fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $432K.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $703M portfolio in Q1 2021.
- NJ State Employees Deferred Compensation Plan opened 17 new positions and closed 7 in Q1 2021.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 8.5% quarter-over-quarter to $703M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2021, filed 26 Apr 2021.